{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:35:03Z","timestamp":1790112903455,"version":"4.0.1"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005612","name":"Shionogi and Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Government of Japan Ministry of Health Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vaccine.2026.128871","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:46:52Z","timestamp":1783122412000},"page":"128871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study"],"prefix":"10.1016","volume":"88","author":[{"given":"Takashi","family":"Nakano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Suganuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouta","family":"Saiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Nakajima-Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Omoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Yazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuhiro","family":"Sonoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128871_bb0005","first-page":"157","article-title":"WHO declares COVID-19 a pandemic","volume":"91","author":"Cucinotta","year":"2020","journal-title":"Acta Biomed"},{"key":"10.1016\/j.vaccine.2026.128871_bb0010","unstructured":"COVID-19 coronavirus statistics. Worldometer, https:\/\/www.worldometers.info\/coronavirus\/#countries; 2026 [accessed 19 January 2026]."},{"key":"10.1016\/j.vaccine.2026.128871_bb0015","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/jmv.27588","article-title":"Omicron variant of SARS-CoV-2: genomics, transmissibility, and responses to current COVID-19 vaccines","volume":"94","author":"Araf","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.vaccine.2026.128871_bb0020","unstructured":"Ministry of Health, Labour and Welfare, Japan. Materials from the 2nd meeting of the Research, Development, Production and Distribution Subcommittee of the Immunization and Vaccine Subcommittee of the Health and Science Council, https:\/\/www.mhlw.go.jp\/stf\/shingi2\/newpage_00104.html; 2026 [accessed 20 January 2026]."},{"key":"10.1016\/j.vaccine.2026.128871_bb0025","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2562730","article-title":"Development and characterization of a bivalent mRNA vaccine targeting the Delta and Omicron variants of SARS-CoV-2","volume":"21","author":"Xiong","year":"2025","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.vaccine.2026.128871_bb0030","article-title":"Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant","author":"Scheaffer","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.vaccine.2026.128871_bb0035","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1080\/14760584.2022.2098719","article-title":"Comparing reactogenicity of COVID-19 vaccines: a systematic review and meta-analysis","volume":"21","author":"Sutton","year":"2022","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.vaccine.2026.128871_bb0040","doi-asserted-by":"crossref","first-page":"9830","DOI":"10.1038\/s41598-024-57308-3","article-title":"A phase 3 randomized controlled trial of a COVID-19 recombinant vaccine S-268019-b versus ChAdOx1 nCoV-19 in Japanese adults","volume":"14","author":"Iwata","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.vaccine.2026.128871_bb0045","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1016\/j.vaccine.2022.04.054","article-title":"Phase 1\/2 clinical trial of COVID-19 vaccine in Japanese participants: a report of interim findings","volume":"40","author":"Iwata","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128871_bb0050","article-title":"Comparison of immune responses elicited by SARS-CoV-2 mRNA and recombinant protein vaccine candidates","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vaccine.2026.128871_bb0055","article-title":"Immunogenicity of the monovalent Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine against XBB.1.5, BA.2.86, and JN.1 sublineages: a phase 2\/3 trial","volume":"12","author":"Gayed","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.128871_bb0060","article-title":"Effectiveness of updated 2023\u20132024 (monovalent XBB.1.5) COVID-19 vaccination against SARS-CoV-2 Omicron XBB and BA.2.86\/JN.1 lineage hospitalization and a comparison of clinical severity\u2014IVY network, 26 hospitals, 18 October 2023\u20139 March 2024","author":"Ma","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.128871_bb0065","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41392-021-00759-1","article-title":"Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.vaccine.2026.128871_bb0070","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa2026920","article-title":"Phase 1\u20132 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine","volume":"383","author":"Keech","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vaccine.2026.128871_bb0075","article-title":"NVX-CoV2373 vaccination induces functional SARS-CoV-2-specific CD4+ and CD8+ T-cell responses","volume":"132","author":"Moderbacher","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vaccine.2026.128871_bb0085","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.15585\/mmwr.mm7039e4","article-title":"Safety monitoring of an additional dose of COVID-19 vaccine\u2014United States, August 12\u2013September 19, 2021","volume":"70","author":"Hause","year":"2021","journal-title":"MMWR Morb. Mortal Wkly. Rep."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26006808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26006808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:38:34Z","timestamp":1789504714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26006808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":16,"alternative-id":["S0264410X26006808"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128871","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128871"}}